The post DOGE and XRP Make History as Grayscale Launches Dual ETF Listing on NYSE appeared on BitcoinEthereumNews.com. Altcoins The next big milestone in the U.S. crypto investment landscape isn’t coming from Bitcoin or Ethereum. Key Takeaways Grayscale’s spot Dogecoin and XRP ETFs will begin trading on the New York Stock Exchange on November 24 The launches allow investors to gain exposure to DOGE and XRP without directly holding the tokens Futures and derivatives activity indicates that traders are preparing aggressively ahead of the first trading session  Instead, two assets once dismissed as speculative outliers are about to step into one of the most respected arenas in global finance. On November 24, both Dogecoin and XRP will begin trading on the New York Stock Exchange as spot exchange-traded funds managed by Grayscale. For the first time, mainstream investors will be able to gain direct price exposure to these tokens through regulated ETF shares rather than holding the cryptocurrencies themselves. A Regulatory Approval That Surfaced Quietly The approval did not debut through a high-profile announcement. It appeared through a regulatory filing sent to the U.S. Securities and Exchange Commission, confirming that the NYSE had authorized the listing. The information gained momentum only after Bloomberg ETF analyst Eric Balchunas publicly shared the update on X, noting that both the Grayscale Dogecoin ETF (GDOG) and the XRP spot ETF would launch together. Balchunas also suggested that a Chainlink ETF may follow roughly one week later. Grayscale Dogecoin ETF $GDOG approved for listing on NYSE, scheduled to begin trading Monday. Their XRP spot is also launching on Monday. $GLNK coming soon as well, week after I think pic.twitter.com/c6nKUeDrtI — Eric Balchunas (@EricBalchunas) November 21, 2025 Wall Street Exposure Without Crypto Onboarding The listings carry weight because they transform how investors can access DOGE and XRP. Until now, participation required navigating crypto exchanges, custody tools, and wallet management. ETF access removes those frictions,… The post DOGE and XRP Make History as Grayscale Launches Dual ETF Listing on NYSE appeared on BitcoinEthereumNews.com. Altcoins The next big milestone in the U.S. crypto investment landscape isn’t coming from Bitcoin or Ethereum. Key Takeaways Grayscale’s spot Dogecoin and XRP ETFs will begin trading on the New York Stock Exchange on November 24 The launches allow investors to gain exposure to DOGE and XRP without directly holding the tokens Futures and derivatives activity indicates that traders are preparing aggressively ahead of the first trading session  Instead, two assets once dismissed as speculative outliers are about to step into one of the most respected arenas in global finance. On November 24, both Dogecoin and XRP will begin trading on the New York Stock Exchange as spot exchange-traded funds managed by Grayscale. For the first time, mainstream investors will be able to gain direct price exposure to these tokens through regulated ETF shares rather than holding the cryptocurrencies themselves. A Regulatory Approval That Surfaced Quietly The approval did not debut through a high-profile announcement. It appeared through a regulatory filing sent to the U.S. Securities and Exchange Commission, confirming that the NYSE had authorized the listing. The information gained momentum only after Bloomberg ETF analyst Eric Balchunas publicly shared the update on X, noting that both the Grayscale Dogecoin ETF (GDOG) and the XRP spot ETF would launch together. Balchunas also suggested that a Chainlink ETF may follow roughly one week later. Grayscale Dogecoin ETF $GDOG approved for listing on NYSE, scheduled to begin trading Monday. Their XRP spot is also launching on Monday. $GLNK coming soon as well, week after I think pic.twitter.com/c6nKUeDrtI — Eric Balchunas (@EricBalchunas) November 21, 2025 Wall Street Exposure Without Crypto Onboarding The listings carry weight because they transform how investors can access DOGE and XRP. Until now, participation required navigating crypto exchanges, custody tools, and wallet management. ETF access removes those frictions,…

DOGE and XRP Make History as Grayscale Launches Dual ETF Listing on NYSE

Altcoins

The next big milestone in the U.S. crypto investment landscape isn’t coming from Bitcoin or Ethereum.

Key Takeaways

  • Grayscale’s spot Dogecoin and XRP ETFs will begin trading on the New York Stock Exchange on November 24
  • The launches allow investors to gain exposure to DOGE and XRP without directly holding the tokens
  • Futures and derivatives activity indicates that traders are preparing aggressively ahead of the first trading session 

Instead, two assets once dismissed as speculative outliers are about to step into one of the most respected arenas in global finance.

On November 24, both Dogecoin and XRP will begin trading on the New York Stock Exchange as spot exchange-traded funds managed by Grayscale. For the first time, mainstream investors will be able to gain direct price exposure to these tokens through regulated ETF shares rather than holding the cryptocurrencies themselves.

A Regulatory Approval That Surfaced Quietly

The approval did not debut through a high-profile announcement. It appeared through a regulatory filing sent to the U.S. Securities and Exchange Commission, confirming that the NYSE had authorized the listing.

The information gained momentum only after Bloomberg ETF analyst Eric Balchunas publicly shared the update on X, noting that both the Grayscale Dogecoin ETF (GDOG) and the XRP spot ETF would launch together. Balchunas also suggested that a Chainlink ETF may follow roughly one week later.

Wall Street Exposure Without Crypto Onboarding

The listings carry weight because they transform how investors can access DOGE and XRP. Until now, participation required navigating crypto exchanges, custody tools, and wallet management.

ETF access removes those frictions, making both assets reachable through brokerage accounts, retirement portfolios, and traditional investment frameworks. That shift opens the door to an entirely new demographic of capital — one that has historically remained outside speculative altcoin markets.

Traders Are Positioning Before the Opening Bell

Momentum is already visible in futures and derivatives markets. Dogecoin’s trading volume has climbed sharply as price action swung between lows near $0.134 and recoveries toward $0.14, signaling heightened speculation ahead of the ETF debut.

XRP has demonstrated even more dramatic volatility, bouncing from around $1.85 to roughly $1.96 as leveraged traders attempt to anticipate the impact of the launch. These patterns typically precede major ETF-driven liquidity events.

A Landmark Moment for Altcoins

Two spot altcoin ETFs launching on the same day in the United States is unprecedented. If interest materializes as predicted, November 24 could establish Dogecoin and XRP as the first major proof that regulated crypto ETFs are not limited to Bitcoin and Ethereum. Grayscale appears positioned to capitalize on this momentum, reinforcing its expansion strategy with a recent U.S. IPO filing that signals ambitions far beyond the current product lineup.


The information provided in this article is for educational purposes only and does not constitute financial, investment, or trading advice. Coindoo.com does not endorse or recommend any specific investment strategy or cryptocurrency. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.

Author

Alexander Zdravkov is a person who always looks for the logic behind things. He has more than 3 years of experience in the crypto space, where he skillfully identifies new trends in the world of digital currencies. Whether providing in-depth analysis or daily reports on all topics, his deep understanding and enthusiasm for what he does make him a valuable member of the team.

Next article

Source: https://coindoo.com/doge-and-xrp-make-history-as-grayscale-launches-dual-etf-listing-on-nyse/

Market Opportunity
DOGE Logo
DOGE Price(DOGE)
$0.13989
$0.13989$0.13989
-1.61%
USD
DOGE (DOGE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26